×

Kim MH, Kim CG, Kim SK, Shin SJ, Choe EA, Park SH, Shin EC, Kim J, YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma, Cancer Immunology Research, Cancer Immunol Res.

Kim MH, Kim J. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies. Cell Mol Life Sci. 2017 Apr;74(8):1457-1474 (First Author and Co-corresponding Author

Kim MH, Kim J, Hong H, Lee SH, Lee JK, Jung E, Kim J, Actin Remodeling Confers BRAF Inhibitor Resistance to Melanoma Cells through YAP/TAZ Activation, The EMBO Journal 2016 Mar 1;35(5):462-78 (Journal Cover)

Kim MH, Lee S, Koo JS, Jung KH, Park IH, Jeong J, Kim SI, Park S, Park HS, Park BW, Kim JH, Sohn J., Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication. PLoS One. 2015 Mar 24;10(3)

Kim MH, Shim HS, Kang DR, Jung JY, Lee CY, Kim DJ, Lee JG, Bae MK, Kim HR, Lim SM, Kim EY, Park JS, Chung KY, Kim HJ, Kim JH, Cho BC., Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma., Lung Cancer. 2014 Mar;83(3):389-95.

Kim MH, Kim HR, Cho BC, Bae MK, Kim EY, Lee CY, Lee JS, Kang DR, Kim JH., Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations., Lung Cancer. 2014 May;84(2):196-202.

Kim MH, Koo JS, Lee S., FOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients., Oncology. 2013;85(2):128-36.

Kim MH, Park Y, Park HJ, Ji AY, Song C, Jin MN, Kim YJ, Kim SW, Lee JH, Kim IS, Kim HR, Kim J, Cho BC, A Favorable Treatment Response of Erlotinib in Lung Adenocarcinoma with Concomitant Activating EGFR Mutation and ROS1 Rearrangement, Ewha Med J. 2014 Mar;37(1):46-51

Kim MH, Kim MS, Cha YJ, Park KS, Kim BS, Lee S, Successful Sirolimus Treatment of Multiple Visceral Kaposi's Sarcoma in a Renal Allograft Patient, J Korean Soc Transplant. 2012 Dec;26(4):293-298

Kim C, Yoo KH, Kim MH, Chon HJ, Lee SI, Lee HJ, Koh S, Lee HY, Lee HR, Kim KS, Choi YD, Rha SY, Lee SJ, Kim HS. Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma. APMIS. 2017 Mar;125(3):223-229.

Kim J, Jo H, Hong H, Kim MH, Kim JM, Lee JK, Heo WD, Kim J, Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking, Nat Commun. 2015 Apr 7;6:6781.

Leem AY, Kim HS, Yoo BW, Kang BD, Kim MH, Rha SY, Kim HS., Ifosfamide-induced Fanconi syndrome with diabetes insipidus., Korean J Intern Med. 2014 Mar;29(2):246-9.

Kim GR, Kim MH, Choi SY, Lee YW, Park JW, Hong CS, Difference of Dermatophagoides farinae Specific IgE Binding Patterns between Asthmatics and Atopic Dermatitis Patients, Journal of asthma, allergy and clinical immunology, Vol.28 No.3 [2008]

신장 재이식 환자의 다발성 내장 침범 카포시육종에서 Sirolimus 치료를 통한 부분 관해 및 이식신 보존 1예
대한이식학회지 26/4 :293-298,2012

FOXP3 Expression Is Related to High Ki-67 Index and Poor Prognosis in Lymph Node-Positive Breast Cancer Patients
ONCOLOGY 85/2 :128-136,2013

Changing treatment patterns in elderly patients with resectable colon cancer
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9/3 :265-272,2013

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma
LUNG CANCER 83/3 :389-395,2014

Ifosfamide-induced Fanconi syndrome with diabetes insipidus
KOREAN JOURNAL OF INTERNAL MEDICINE 29/2 :246-249,2014

Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
LUNG CANCER 84/2 :196-202,2014

EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E-Mutant NSCLC Cell Lines
MOLECULAR CANCER THERAPEUTICS 15/7 :1,627-1,636,2016

Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma
APMIS 125/3 :223-229,2017

Can We Prevent Resistance to Osimertinib? Combination or Sequential
JOURNAL OF THORACIC ONCOLOGY 13/7 :877-879,2018

Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater
CANCER IMMUNOLOGY IMMUNOTHERAPY 68/3 :443-454,2019

Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
CANCER RESEARCH AND TREATMENT 51/2 :819-831,2019

Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer
ONCOLOGIST 24/11 :e1108-e1114,2019